Study S001896

An Open, Fixed-sequence, Self-controlled Pharmacokinetic Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects

ClinicalTrials.gov record

Registration

Registration: NCT07269756
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 40
Start: 2025-12-07
Primary completion: 2026-03-08
Lead sponsor: Shandong Suncadia Medicine Co., Ltd.
Conditions: Obesity; Overweight
Interventions: DRUG:HRS-7535 Tablets; DRUG:Paracetamol Tablets; DRUG:Digoxin Tablets; DRUG:Rosuvastatin Calcium Tablets; DRUG:Omeprazole Enteric-coated Capsules
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Maximum concentration (Cmax) [63 days.]
Area under the concentration-time curve from time zero to the time of the last quantifiable concentration (AUC0-last) [63 days.]
Area under the concentration-time curve from time zero to infinity (AUC0-inf) [63 days.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.